Kronox Lab Sciences
- Market cap
- ₹ 740 Cr.
- P/E
- 24.6x
- P/B
- 6.3x
- 52-week range
- 96 – 227.74
- ROE
- 27%
- ROCE
- 36%
- Dividend yield
- 0.3%
- Debt / equity
- 0.01
- Sector
- Chemicals & Petrochemicals
- Industry
- Specialty Chemicals
- Listed on
- NSE, BSE
About
Kronox Lab Sciences Limited is an India-based company engaged in the manufacturing of high purity fine, inorganic chemicals, phosphate and metallic chemicals. It is a bulk manufacturer of high purity fine chemicals for the pharmaceutical, nutraceutical, veterinary, food, chemical analysis and other specialty markets. The Company offers a line of chemicals including acetates, carbonates, chlorides, citrates, nitrates, nitrites, phosphates, sulfates, and ultrapure metallic salts. The Company’s product range includes ACS Reagent, LR, AR and GR Reagents, Oral Care, Pharmacopoeia, Food and Nutraceutical, Personal Care and Cosmetics, Veterinary Pharma and Animal Health, Tartrates, Citrates, Hypophosphites, Phosphates, Hydroxides, Ethylenediaminetetraacetic acid (EDTA) and Derivatives, Ultra High Purity Chemicals, Custom Specification, and Specialty Anhydrous. It manufactures high purity specialty fine chemicals of various grades in particle sizes ranging from 10 mesh to 100 mesh.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Specialty Chemicals: 130 companies →Kronox Lab Sciences against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)24.6 against a typical 26.3: cheaper than most peers (1st = cheapest).59th of 129
- Sales growth+16.9% against a typical +25.9% from a year earlier.80th of 112
- Profit growth+16.2% against a typical +42.4% from a year earlier.70th of 102
- Share price, 3 months+26.1% against a typical −5.5%.17th of 118
- Size₹ 740.3 Cr. market value against a typical ₹ 359.6 Cr. (1st = largest).51st of 126
Latest announcements
Exchange filings and their impact on the company.
- Ex-promoters' 9.95% stake freed from lock-in, creating ~Rs 77 cr share overhang.
Kronox Lab Sciences said its 64.26% share purchase deal with Indo Borax & Chemicals was amended on October 22, 2026. The change removes the lock-in on the former promoters' remaining 9.95% stake and removes Indo Borax's first-refusal right on those shares. Control is unchanged, but the former promoters can now freely sell their shares.
- Kronox to buy a 5,000 sqm Dahej SEZ chemical plant for cash to expand capacity.
Kronox Lab Sciences board on October 14, 2026 approved buying a 5,000 sqm plant at Dahej SEZ from Axiom Chemicals Private Limited. It is an asset-only, non-related-party cash deal to expand manufacturing capacity, to be funded from internal accruals and closed within a month subject to SEZ and other approvals. Price was not disclosed. The addition is material for a company with about Rs 105 crore annual sales and should support revenue growth over the next year after ramp-up.
Board meetings
Results dates and other board meetings. Full calendar
| Details | ||
|---|---|---|
| 12 Aug 2026 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2026 |
| 21 May 2026 | Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2026 and dividend |
| 14 Feb 2026 | Financial Results | To consider and approve the financial results for the period ended December 31, 2025 |
| 11 Nov 2025 | Financial Results | To consider and approve the financial results for the period ended September 30, 2025 |
| 11 Aug 2025 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2025 |
| 22 May 2025 | Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2025 and dividend |
Financials
Standalone figures in ₹ crore.
| ₹ Cr. | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 21 | 21 | 22 | 25 | 25 | 24 | 26 | 24 | 26 | 25 | 26 | 28 |
| Expenses | 15 | 15 | 14 | 17 | 16 | 16 | 18 | 16 | 17 | 17 | 17 | 19 |
| Operating Profit | 6 | 6 | 8 | 8 | 9 | 8 | 8 | 8 | 9 | 8 | 10 | 9 |
| OPM % | 27.9% | 29.4% | 35.4% | 32.6% | 35.4% | 34.8% | 29.7% | 32.8% | 33.9% | 31.8% | 36.4% | 31.7% |
| Other Income | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 2 | 1 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
| Profit before tax | 6 | 6 | 8 | 8 | 9 | 9 | 8 | 8 | 9 | 9 | 11 | 10 |
| Tax % | 27.1% | 18.3% | 29.9% | 26% | 26.6% | 26.1% | 24.1% | 25.7% | 27.2% | 23.4% | 27% | 25.6% |
| Net Profit | 4 | 5 | 6 | 6 | 6 | 7 | 6 | 6 | 7 | 7 | 8 | 7 |
| EPS in Rs | 1.17 | 1.28 | 1.58 | 1.66 | 1.74 | 1.76 | 1.7 | 1.69 | 1.8 | 1.78 | 2.16 | 1.97 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- —
- 5 Years
- 10%
- 3 Years
- 2%
- TTM
- 6%
- 10 Years
- —
- 5 Years
- 23%
- 3 Years
- 19%
- TTM
- 12%
- 10 Years
- —
- 5 Years
- —
- 3 Years
- —
- TTM
- —
- 10 Years
- —
- 5 Years
- 33%
- 3 Years
- 31%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| Kronox Lab Sciences | ₹ 196.48 | ₹ 740 Cr. | 24.6x | 6.3x | 27% | — |
| Asian Paints | ₹ 2,305.00 | ₹ 2,21,095 Cr. | 58.1x | 12.1x | 21.2% | 12.4% |
| Solar Industries India | ₹ 18,320.00 | ₹ 1,65,778 Cr. | 99.6x | 26.6x | 31.4% | 17.7% |
| Pidilite Industries | ₹ 1,514.00 | ₹ 1,54,107 Cr. | 64.8x | 14.7x | 23.8% | 16.9% |
| SRF | ₹ 2,309.00 | ₹ 68,444 Cr. | 44.6x | 6.1x | 13.8% | 11.6% |
| Linde India | ₹ 5,697.00 | ₹ 48,586 Cr. | 110.5x | 14.2x | 13.6% | 21.7% |
Management
- Jogindersingh Gianchand Jaswal
- Executive Chairman of the Board, Managing Director
- Samir Rajnikantbhai Gadhiya
- Chief Financial Officer
- Nikhil Goswami
- Company Secretary, Compliance Officer
- Pritesh Vinodchandra Ramani
- Whole Time Director
Prices are delayed and for information only. Nothing on this page is investment advice.